Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 5
Submit an article Journal homepage
1,863
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

JQ1 reduces Epstein–Barr virus-associated lymphoproliferative disease in mice without sustained oncogene repression

Amanda HeDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA; ;Gladstone Institute of Virology and Immunology, San Francisco, CA, USAView further author information
&
JJ L. MirandaDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA, USA; ;Gladstone Institute of Virology and Immunology, San Francisco, CA, USACorrespondence[email protected]
View further author information
Pages 1248-1251 | Received 13 Jun 2017, Accepted 19 Aug 2017, Published online: 08 Sep 2017

References

  • Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains. Nature. 2010;468:1067–1073.
  • Nicodeme E, Jeffrey KL, Schaefer U, et al. Suppression of inflammation by a synthetic histone mimic. Nature. 2010;468:1119–1123
  • Mertz JA, Conery AR, Bryant BM, et al. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci USA. 2011;108:16669–16674.
  • Chapuy B, McKeown MR, Lin CY, et al. Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell. 2013;24:777–790.
  • Tolani B, Gopalakrishnan R, Punj V, et al. Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors. Oncogene. 2014;33:2928–2937.
  • Zhou H, Schmidt SC, Jiang S, et al. Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell Host Microbe. 2015;17:205–216.
  • Phan AT, Fernandez SG, Somberg JJ, et al. Epstein-Barr virus latency type and spontaneous reactivation predict lytic induction levels. Biochem Biophys Res Commun. 2016;474:71–75.
  • Thomas JA, Hotchin NA, Allday MJ, et al. Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation. 1990;49:944–953.
  • Hong GK, Gulley ML, Feng WH, et al. Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model. J Virol. 2005;79:13993–14003.
  • Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74.
  • Afgan E, Baker D, van den Beek M, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 2016;44:W3–W10.
  • Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357–360.
  • Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–930.
  • Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
  • Keck KM, Moquin SA, He A, et al. Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps. J Biol Chem. 2017;292:13284–13295.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.